- Home
- / Nova Mentis Life Science
Nova Mentis Life Science
Stock Price
$0
2024-10-29
Market Capitalization
$830.6 K
2024-10-29
Nova Mentis Life Science Summary
Company Summary
- Overview
- Nova Mentis Life Science is a biotechnology company that provides psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. It diagnoses and treats debilitating chronic conditions such as autism spectrum disorder and fragile X syndrome.
- Type
- Public
- Status
- Active
- Founded
- 2004
- Website
- https://www.novamentis.ca
- Cybersecurity rating
Table of Contents
Nova Mentis Life Science Financials
Summary Financials
- Net income (Q3, 2025)
- ($C211.0K)
- Cash (Q3, 2025)
- $C87.0K
- EBIT (Q3, 2025)
- ($C211.0K)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026